BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 34993057)

  • 1. Masseter muscle parameters can function as an alternative for skeletal muscle mass assessments on cross-sectional imaging at lumbar or cervical vertebral levels.
    van Heusden HC; Chargi N; Dankbaar JW; Smid EJ; de Bree R
    Quant Imaging Med Surg; 2022 Jan; 12(1):15-27. PubMed ID: 34993057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of head and neck computed tomography for skeletal muscle mass estimation in patients with head and neck cancer.
    Jung AR; Roh JL; Kim JS; Choi SH; Nam SY; Kim SY
    Oral Oncol; 2019 Aug; 95():95-99. PubMed ID: 31345401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of skeletal muscle mass assessment at the level of the third cervical vertebra in patients with head and neck cancer.
    Bril SI; Chargi N; Wendrich AW; Wegner I; Bol GH; Smid EJ; de Jong PA; Devriese LA; de Bree R
    Oral Oncol; 2021 Dec; 123():105617. PubMed ID: 34749251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility of assessment of skeletal muscle mass on a single cross-sectional image at the level of the fourth thoracic vertebra.
    van Heusden HC; Swartz JE; Chargi N; de Jong PA; van Baal MCPM; Wegner I; de Bree R
    Eur J Radiol; 2021 Sep; 142():109879. PubMed ID: 34343845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effectiveness of skeletal muscle evaluation at the third cervical vertebral level for computed tomography-defined sarcopenia assessment in patients with head and neck cancer.
    Vangelov B; Bauer J; Moses D; Smee R
    Head Neck; 2022 May; 44(5):1047-1056. PubMed ID: 35138008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of alternate vertebral levels to L3 in computed tomography scans for skeletal muscle mass evaluation and sarcopenia assessment in patients with cancer: a systematic review.
    Vangelov B; Bauer J; Kotevski D; Smee RI
    Br J Nutr; 2022 Mar; 127(5):722-735. PubMed ID: 33910664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skeletal muscle mass at C3 may not be a strong predictor for skeletal muscle mass at L3 in sarcopenic patients with head and neck cancer.
    Yoon JK; Jang JY; An YS; Lee SJ
    PLoS One; 2021; 16(7):e0254844. PubMed ID: 34280248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing skeletal muscle mass based on the cross-sectional area of muscles at the 12th thoracic vertebra level on computed tomography in patients with oral squamous cell carcinoma.
    Matsuyama R; Maeda K; Yamanaka Y; Ishida Y; Kato R; Nonogaki T; Shimizu A; Ueshima J; Kazaoka Y; Hayashi T; Ito K; Furuhashi A; Ono T; Mori N
    Oral Oncol; 2021 Feb; 113():105126. PubMed ID: 33388617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility of using head and neck CT imaging to assess skeletal muscle mass in head and neck cancer patients.
    Swartz JE; Pothen AJ; Wegner I; Smid EJ; Swart KM; de Bree R; Leenen LP; Grolman W
    Oral Oncol; 2016 Nov; 62():28-33. PubMed ID: 27865369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Muscle Quantity at C3 and/or L3 on Routine Trauma Series Computed Tomography Correlate With Brain Frailty and Clinical Frailty Scale: A Cross-Sectional Study.
    Gomindes AR; Appleton JP; Chugh R; Welch C
    Cureus; 2021 Jun; 13(6):e15912. PubMed ID: 34336420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fully-automated sarcopenia assessment in head and neck cancer: development and external validation of a deep learning pipeline.
    Ye Z; Saraf A; Ravipati Y; Hoebers F; Zha Y; Zapaishchykova A; Likitlersuang J; Tishler RB; Schoenfeld JD; Margalit DN; Haddad RI; Mak RH; Naser M; Wahid KA; Sahlsten J; Jaskari J; Kaski K; Mäkitie AA; Fuller CD; Aerts HJWL; Kann BH
    medRxiv; 2023 Mar; ():. PubMed ID: 36945519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computed tomography-based psoas skeletal muscle area and radiodensity are poor sentinels for whole L3 skeletal muscle values.
    Rollins KE; Gopinath A; Awwad A; Macdonald IA; Lobo DN
    Clin Nutr; 2020 Jul; 39(7):2227-2232. PubMed ID: 31668722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prediction model for skeletal muscle evaluation and computed tomography-defined sarcopenia diagnosis in a predominantly overweight cohort of patients with head and neck cancer.
    Vangelov B; Bauer J; Moses D; Smee R
    Eur Arch Otorhinolaryngol; 2023 Jan; 280(1):321-328. PubMed ID: 35835910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interobserver agreement of skeletal muscle mass measurement on head and neck CT imaging at the level of the third cervical vertebra.
    Bril SI; Wendrich AW; Swartz JE; Wegner I; Pameijer F; Smid EJ; Bol GH; Pothen AJ; de Bree R
    Eur Arch Otorhinolaryngol; 2019 Apr; 276(4):1175-1182. PubMed ID: 30689037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Skeletal Muscle Changes at Three Vertebral Levels Following Radiotherapy in Patients With Oropharyngeal Carcinoma.
    Vangelov B; Bauer J; Moses D; Smee R
    Nutr Cancer; 2023; 75(2):572-581. PubMed ID: 36308327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skeletal muscle mass and sarcopenia can be determined with 1.5-T and 3-T neck MRI scans, in the event that no neck CT scan is performed.
    Zwart AT; Becker JN; Lamers MJ; Dierckx RAJO; de Bock GH; Halmos GB; van der Hoorn A
    Eur Radiol; 2021 Jun; 31(6):4053-4062. PubMed ID: 33219847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skeletal Muscle Depletion and Major Postoperative Complications in Locally-Advanced Head and Neck Cancer: A Comparison between Ultrasound of Rectus Femoris Muscle and Neck Cross-Sectional Imaging.
    Galli A; Colombo M; Prizio C; Carrara G; Lira Luce F; Paesano PL; Della Vecchia G; Giordano L; Bondi S; Tulli M; Di Santo D; Mirabile A; De Cobelli F; Bussi M
    Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating the prognosis of oral squamous cell carcinoma patients via L3 skeletal muscle index.
    Lu X; Tian Y; Huang J; Li F; Shao T; Huang G; Lv X
    Oral Dis; 2023 Apr; 29(3):923-932. PubMed ID: 34773352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of the second thoracic vertebral landmark for skeletal muscle assessment and computed tomography-defined sarcopenia evaluation in patients with head and neck cancer.
    Vangelov B; Bauer J; Moses D; Smee R
    Head Neck; 2023 Apr; 45(4):1006-1016. PubMed ID: 36811256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low skeletal muscle mass assessed directly from the 3rd cervical vertebra can predict pharyngocutaneous fistula risk after total laryngectomy in the male population.
    Casasayas M; García-Lorenzo J; Gómez-Ansón B; Medina V; Fernández A; Quer M; León X
    Eur Arch Otorhinolaryngol; 2022 Feb; 279(2):853-863. PubMed ID: 34665301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.